Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Tepezza Hearing Damage Lawsuit Filed Against Makers of Thyroid Eye Disease Drug Lawsuit alleges no warnings or information was provided about the risk of hearing damage from Tepezza, which could have been avoided with medical monitoring February 16, 2023 Irvin Jackson Add Your Comments A California woman has filed a product liability lawsuit against Horizon Therapeutics, alleging that the drug maker failed to adequately warn about the potential hearing damage side effects from Tepezza, a blockbuster injection for treatment of thyroid eye disease, indicating users could have avoided permanent hearing loss if medical or audiological monitoring had been recommended to doctors. Tepezza (teprotumumab-trbw) is a new-generation biologic treatment which was just introduced in January 2020, as the first medication approved to treat thyroid eye disease or bulging eyes, which is caused by hyperthyroidism and linked to Graves’ disease, resulting in inflammation of eye muscles, eyelids, tear glands and fatty tissues behind the eye. Although Tepezza was originally intended as a niche treatment, with only a limited market, during the second year the drug was on the market in the United States sales doubled to $1.66 billion, and critics have expressed concern that Tepezza was aggressively marketed without adequately disclosing all of the potential risks. Over the past three years, hundreds of users have reported experiencing various forms of hearing damage from Tepezza, including tinnitus (ringing in the ears), hearing loss and complete deafness, with many of the problems persisting long after last use of the medication. Tepezza Lawsuits Did You or a Loved One Receive a Tepezza Injection? Side effects of Tepezza may cause permanent hearing problems. Lawsuits are being pursued over the drug maker’s failure to warn about the risk. Find out if qualify for a settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Tepezza Lawsuits Did You or a Loved One Receive a Tepezza Injection? Side effects of Tepezza may cause permanent hearing problems. Lawsuits are being pursued over the drug maker’s failure to warn about the risk. Find out if qualify for a settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a complaint (PDF) filed in the U.S. District Court for the Northern District of Illinois on February 14, Norma Perez Diaz indicates that her physician administered Tepezza infusions from November 2021 through April 2022, following a diagnosis of thyroid eye disease and Graves’ disease. However, neither she nor her doctor were ever provided any warnings about the risk of Tepezza hearing damage or the importance of conducting baseline audiological testing before treatment, or monitoring for hearing loss following infusions. As a result of the treatments, Diaz indicates that she now suffers from hearing loss and tinnitus, which she indicates is permanent and irreversible. Failure to Warn About Tepezza Hearing Damage The case joins a growing number of Tepezza lawsuits filed over the past few months by individuals left with permanent hearing damage, alleging that Horizon knew or should have known about the risk before the drug was ever introduced. However, rather than disclosing the information to doctors and the medical community, the drug maker placed it’s desire for profits before the safety and wellbeing of users. “Plaintiff and Plaintiff’s physicians were given no warning and had no knowledge of the serious risk of permanent hearing loss and/or tinnitus Tepezza posed,” the lawsuit states. “Specifically… there is no warning or indication that Tepezza can, and in fact does, cause permanent hearing damage. Nor are physicians directed by Defendant to conduct baseline audiology testing before treatment with Tepezza, or monitor hearing acuity during treatment.” The lawsuit details hundreds of adverse event reports submitted to the drug maker involving users who experienced hearing damage from Tepezza, and the repeated decisions by the drug maker to provide false or misleading warnings about the potential Tepezza side effects. “Despite adverse-event reports from healthcare professionals and consumers around the world, Defendant never adequately warned of the risk of serious and irreversible hearing loss, including, but not limited to, hearing loss and tinnitus, associated with using Tepezza,” according to the complaint. February 2023 Tepezza Lawsuit Update Diaz’s complaint joins nearly a dozen Tepezza lawsuits already pending in the the U.S. District Court for the Northern District of Illinois, where a group of plaintiffs filed a motion to centralize the Tepezza cases before one judge in December 2022, to avoid duplicative discovery in different cases, contradictory pretrial rulings and conflicting scheduling orders. Although the size and scope of the litigation is expected to continue to increase rapidly, Horizon Therapeutics has objected to the proposed consolidation, claiming the cases involve substantially enough different facts and defenses that they would not benefit from coordinated pretrial proceedings. Instead, the drug maker has filed motions to dismiss Tepezza hearing loss claims, arguing that it should be insulated from liability for failing to warn under a theory of federal preemption, arguing that the FDA would have to approve a label update. Plaintiffs maintain that ultimate responsibility for the safety and warnings provided falls on the drug maker, indicating that if they are going to sell and profit from a medication they need to conduct adequate research and disclose all known or knowable risk information. Tepezza is an insulin-like growth factor 1 receptor (IGF-IR) inhibitor medication, and plaintiffs maintain that it is well known that IGF-I is crucial to protecting the inner ear hair cells from noise-induced hearing damage, ischemia and medication toxicity. Therefore, Tepezza lawsuits allege that the drug maker should have recognized that hearing loss would be a potential side effect, and provided warnings about the importance of monitoring during treatment and obtaining hearing tests before use. DID YOU EXPERIENCE HEARING DAMAGE FROM TEPEZZA? Lawyers provide free consultations and claim evaluations to help determine if financial compensation may be available through a Tepezza lawsuit settlement. FIND OUT IF YOU QUALIFY Tags: Graves Disease, Hearing Loss, Horizon Therapeautics, Tepezza, Thyroid Eye Disease, Tinnitus More Tepezza Lawsuit Stories Tepezza Tinnitus and Hearing Loss Lawsuits Move Into Expert Discovery Phase June 11, 2025 Tepezza Lawyers Meet With MDL Judge To Review Status of Hearing Loss Lawsuits Today March 31, 2025 Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 March 25, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 2 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025) Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: 3 days ago) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025) Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: 3 days ago) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)
Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 March 25, 2025
Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 2 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025)
Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: 3 days ago) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)
Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: 3 days ago) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)